BLNP 006Alternative Names: BLNP-006
Latest Information Update: 04 Sep 2015
At a glance
- Originator BL-&-H
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Chemically-induced disorders
Most Recent Events
- 04 Sep 2015 Clinical trials in Chemically induced disorders in South Korea (unspecified route) before September 2015